Replies to post #693160 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

The idea that they possibly looked at the results and changing it toward the end

The idea that they possibly looked at the results...
Do you read your text before posting it. The idea that I possibly could float in the air after jumping out of an airplane is exciting.

Anyway, Sherlock, they were NOT aware of the results when the primary endpoint shifted to OS because that happened in 2018 and data lock did not take place until second half of 2020

[learningcurve2020]

Add to it the messy Pl and ll, as per that article I posted. Investors never saw a PR acknowledging any regulators green lighted the Plll change. About the only positive is that MHRA approved a similar PIP trial using EC. However, there seems to be no interest in running that trial so far.

[Nemesis18]

It isn't laughable. It is seriously a concern. The idea that they possibly looked at the results and changing it toward the end is not something that can be ignored. This is seriously a concern for the integrity of the trial.

I’m both bemused and amused that most here believe that this bastardised Phase III Clinical Trial, and the data ‘produced’ wouldn’t come under intense scrutiny at the regulatory stage !

And I have a sense that other Bodies may be looking at the efficacy of the conclusions drawn about this ‘vaccine’ also.

You can apply any rationale you want to here, as to why the MAA hasn’t been granted yet, and to why no more news is expected until the Fall.

The fact remains, your dreams of overnight riches,are pretty much dead in the water !